Dublin, Dec. 15, 2016 -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "DNA Sequencing - Technologies, Markets and Companies" to their offering.
This report briefly reviews basics of human genome variations, development of sequencing technologies, and their applications. Current large and small sequencers are described as well as companies developing them.
Various applications of sequencing are described including those for genetics, medical diagnostics, drug discovery and cancer. Next generation sequencing technologies, both second and third generations, are reviewed. Companies developing software for analysis of sequencing data are also included. Selected academic institutes conducting research in sequencing are also listed.
Current market is mostly for research applications and future markets will be other applications related to healthcare. The value of DNA sequencer market in 2015 is described with estimates for 2020 and 2025. Various methods and factors on which market estimates depend are described briefly. Markets are tabulated according to geographical areas as well as applications. Small sequencers form the basis of SWOT (strengths, weaknesses, opportunities, threats) analysis. Several marketing strategies have been outlined.
The report includes profiles of 137 companies involved in sequencing and their 145 collaborations. The report text is supplementd by 42 tables, 21 figures and 500 selected references to the literature.
Key Topics Covered:
Executive Summary
1. Introduction
2. DNA Sequencing Technologies
3. Role of Bioinformatics in Sequencing
4. Comparative Analysis of Sequencing Technologies
5. Sequencing for Research
6. Applications of Sequencing in Healthcare
7. Applications of Sequencing in Oncology
8. Sequencing in Genetic Disorders
9. Sequencing in Neurological and Psychiatric Disorders
10. Applications of sequencings in infections
11. Role of Sequencing in Personalized Medicine
12. Current Status and Future Prospects
13. Markets for Sequencers
14. Companies Involved in Sequencing
15. References
For more information about this report visit http://www.researchandmarkets.com/research/r6zngl/dna_sequencing
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Genomics


Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
OpenAI Explores Massive Funding Round at $750 Billion Valuation
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



